Hologic (HOLX) Tops Q1 EPS by 3c; Bumps Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 ends higher as CoreWeave results fuel AI optimism
- Oil prices edge up as investors weigh US-Iran talks deadlock against lower demand
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Hologic (HOLX) PT Raised to $33 at Needham & Company on Strong Q1 Growth Acceleration
January 29, 2015 8:24 AM ESTNeedham & Company analyst Mike Matson reiterated a Buy rating and boosted his price target on Hologic (NASDAQ: HOLX) to $33.00 (from $30.00) following broad-based growth acceleration in Q1.
Matson commented, "HOLX's F1Q15 revenue was consistent with its 1/12/15 preannouncement while EPS beat consensus. Management raised... More
